| Denis Chem Lab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 537536 |
NSE Symbol : - |
P/E(TTM) : 16.61 |
|
ISIN Demat : INE051G01012 |
Div & Yield% : 1.75 |
EPS(TTM) : 5.16 |
|
Book Value(₹) : 63.24 |
Market Cap(₹Cr) : 118.96 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 46.17 | 43.28 | 41.38 | 42.84 | 47.82 | 41.26 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 46.17 | 43.28 | 41.38 | 42.84 | 47.82 | 41.26 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.65 | 0.30 | 1.17 | 0.30 | 0.58 | 0.32 |
| Total Income | 46.82 | 43.58 | 42.56 | 43.14 | 48.40 | 41.58 |
| Total Expenditure | 41.91 | 36.50 | 39.33 | 39.02 | 41.93 | 36.91 |
| PBIDT | 4.91 | 7.08 | 3.23 | 4.12 | 6.46 | 4.67 |
| Interest | 0.23 | 3.58 | 0.23 | 0.07 | 0.09 | 0.12 |
| PBDT | 4.68 | 3.50 | 3.00 | 4.06 | 6.37 | 4.55 |
| Depreciation | 1.65 | 0.19 | 1.73 | 1.84 | 1.66 | 1.63 |
| Tax | 0.28 | 0.93 | 1.01 | 0.03 | 2.04 | 0.86 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.54 | -0.09 | -0.45 | 0.43 | -0.86 | -0.02 |
| Reported Profit After Tax | 2.21 | 2.48 | 0.71 | 1.76 | 3.53 | 2.08 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.21 | 2.48 | 0.71 | 1.76 | 3.53 | 2.08 |
| EPS (Unit Curr.) | 1.60 | 1.78 | 0.51 | 1.27 | 2.54 | 1.50 |
| EPS (Adj) (Unit Curr.) | 1.60 | 1.78 | 0.51 | 1.27 | 2.54 | 1.50 |
| Calculated EPS (Unit Curr.) | 1.59 | 1.78 | 0.51 | 1.27 | 2.54 | 1.50 |
| Calculated EPS (Adj) (Unit Curr.) | 1.59 | 1.78 | 0.51 | 1.27 | 2.54 | 1.50 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.38 | 7.13 | 2.04 | 5.08 | 10.18 | 5.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.38 | 7.13 | 2.04 | 5.08 | 10.18 | 5.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 15.00 | 0.00 | 0.00 | 0.00 | 25.00 | 0.00 |
| Equity | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.63 | 16.36 | 7.81 | 9.62 | 13.51 | 11.32 |
| PBDTM(%) | 10.14 | 8.09 | 7.25 | 9.48 | 13.32 | 11.03 |
| PATM(%) | 4.79 | 5.73 | 1.72 | 4.11 | 7.38 | 5.04 |